Pat B. Zanzonico
Affiliations: | Cornell University, Ithaca, NY, United States |
Google:
"Pat Zanzonico"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Sgouros G, Dewaraja YK, Escorcia F, et al. (2022) Reply LTE, Single time point tumour dosimetry assuming normal distribution of tumour kinetics. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine |
Capala J, Graves SA, Scott A, et al. (2021) Dosimetry for Radiopharmaceutical Therapy: Current Practices and Commercial Resources. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 62: 3S-11S |
Sgouros G, Dewaraja YK, Escorcia F, et al. (2021) Tumor Response to Radiopharmaceutical Therapies: The Knowns and the Unknowns. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 62: 12S-22S |
Divgi C, Carrasquillo JA, Meredith R, et al. (2020) Overcoming Barriers to Radiopharmaceutical Therapy: An Overview from the NRG-NCI Working Group on Dosimetry of Radiopharmaceutical Therapy (RPT). International Journal of Radiation Oncology, Biology, Physics |
Roncali E, Capala J, Benedict SH, et al. (2020) Overview of the First NRG-NCI Workshop on Dosimetry of Systemic Radiopharmaceutical Therapy (RPT). Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine |
Santich BH, Cheal SM, Ahmed M, et al. (2020) A Self-Assembling and DisAssembling (SADA) bispecific antibody (BsAb) platform for curative 2-step pre-targeted radioimmunotherapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
Frost GR, Longo V, Li T, et al. (2020) Hybrid PET/MRI enables high-spatial resolution, quantitative imaging of amyloid plaques in an Alzheimer's disease mouse model. Scientific Reports. 10: 10379 |
Dunphy MP, Pressl C, Pillarsetty N, et al. (2020) First-in-Human Trial of Epichaperome-Targeted Positron Emission Tomography in Cancer Patients. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
Krebs S, Veach DR, Carter LM, et al. (2020) First-in-Human Trial of Dasatinib-Derivative Tracer for Tumor Kinase-Targeted Positron Emission Tomography. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine |
Zhang X, Chen F, Turker MZ, et al. (2020) Targeted melanoma radiotherapy using ultrasmall Lu-labeled α-melanocyte stimulating hormone-functionalized core-shell silica nanoparticles. Biomaterials. 241: 119858 |